VAXNEUVANCE

Merck Canada Inc🇨🇦 Health Canada

Approval Date: Jul 4, 2025
Approval ID: 4451ba35ef96b788
Company: Merck Canada Inc
Type: Standard

Approval Details

Approval Id: 4451ba35ef96b788
Drug Approval Canada Name: VAXNEUVANCE
Product Name: VAXNEUVANCE
Status: Marketed
Status Date: 2022-09-02
Original Market Date: 2022-09-02
Din: 02522403
Drug Class: Human
Dosage Form: Suspension
Route Of Administration: Intramuscular
Schedule: Schedule D
Ahfs: 80:12.00
Atc Original: J07AL02 PNEUMOCOCCUS, PURIFIED POLYSACC.ANTIGEN CONJUGATED
Atc Name: j 07 al 02
Aig Number: 1663275001
Company Name: Merck Canada Inc
Company Address: 16750 Route Transcanadienne, Kirkland, Quebec, Canada, H9H 4M7

Active Ingredients

CORYNEBACTERIUM DIPHTHERIAE CRM-197 PROTEIN

30 MCG / 0.5 ML

PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14

2 MCG / 0.5 ML

PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C

2 MCG / 0.5 ML

PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F

2 MCG / 0.5 ML

PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F

2 MCG / 0.5 ML

PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4

2 MCG / 0.5 ML

PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A

2 MCG / 0.5 ML

PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B

4 MCG / 0.5 ML

PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V

2 MCG / 0.5 ML

PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F

2 MCG / 0.5 ML

PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A

2 MCG / 0.5 ML

PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1

2 MCG / 0.5 ML

PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3

2 MCG / 0.5 ML

PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F

2 MCG / 0.5 ML

PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5

2 MCG / 0.5 ML

PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F

2 MCG / 0.5 ML

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

4451ba35ef96b788

Type

Standard

Back to Health Canada Approvals